시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 대규모 및 소규모 바이오프로세스 시장 보고서(2025년)
Large And Small-Scale Bioprocessing Global Market Report 2025
상품코드 : 1825784
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

대규모 및 소규모 바이오프로세스 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 연평균 성장률(CAGR) 12.6%로 1,088억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 헬스케어 지출 증가, 제약 및 생명공학 분야 확대, 기술 혁신, 규제 압력, 식품 안전에 대한 인식 증가, COVID-19 팬데믹의 여파 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 첨단 기술 채택, 지리적 확장, 멸균 서비스 아웃소싱, 지속가능한 관행, 하이브리드 멸균 기술, 맞춤형 멸균 솔루션 등을 꼽을 수 있습니다.

향후 5년간 12.6%의 성장률 전망은 지난번 예측보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 스웨덴과 싱가포르에서 수입되는 일회용 바이오리액터와 여과 시스템의 비용을 상승시키고, 의약품 제조 지연을 악화시키며, 생물학적 제제 개발 비용을 증가시킴으로써 미국 바이오 제약회사에 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

생물학적 제제에 대한 수요 증가는 향후 대규모 및 소규모 바이오프로세스 시장의 확대를 견인할 것으로 보입니다. 생물학적 제제에는 백신, 혈액 및 혈액성분, 유전자 치료제, 조직, 재조합 치료용 단백질 등 생물 또는 그 성분에서 유래한 의약품이 포함됩니다. 생물학적 제제의 수요가 증가하는 배경에는 생명공학 기술의 발전, 질병 기전에 대한 이해의 향상, 표적 치료제와 맞춤치료에 대한 요구가 있습니다. 생물학적 제제 개발 및 상업화의 성공에는 대규모 바이오 공정과 소규모 바이오 공정이 모두 중요한 역할을 합니다. 소규모 바이오프로세스는 초기 단계의 개발, 최적화 및 타당성 조사에 매우 중요하며, 대규모 바이오프로세스는 상업적 유통을 위한 생물학적 제제의 효율적이고 일관성 있는 규제 준수 생산을 보장합니다. 예를 들어, 미국 의학도서관인 국립의학도서관(National Library of Medicine)에 따르면, 2024년 2월 미국 식품의약국(FDA)은 2023년 29개의 신규 화학제품(NCE)과 25개의 신규 생물학적 제제(NBE)를 포함한 55개의 신약을 승인했습니다. 2022년 37개 승인에 비해 50% 증가했습니다. 따라서 생물학적 제제에 대한 수요 증가는 대규모 및 소규모 바이오프로세스 시장의 성장 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Large and small-scale bioprocessing are critical facets of the biotechnology and pharmaceutical sectors, employing living cells or their components to produce desired outputs such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing denotes the industrial-level manufacturing of biological products, utilizing large bioreactors and substantial infrastructure. Conversely, small-scale bioprocessing entails the production of biological products on a smaller scale, often for research, development, pilot studies, or specialized markets.

The primary products of both large and small-scale bioprocessing encompass bioreactors or fermenters, cell culture items, filtration assemblies, bioreactor accessories, bags, containers, and others. Bioreactors, also known as fermenters, are vessels engineered to facilitate the growth and metabolic processes of microorganisms or cells under controlled conditions to yield desired biological outputs. They are utilized through various modalities, including in-house and outsourced, and cater to several workflows, predominantly downstream processing, fermentation, and upstream processing. These products find application across a range of scales, from industrial to small-scale, and are employed in diverse sectors such as biopharmaceuticals, specialty industrial chemicals, and environmental aids.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The large and small-scale bioprocessing market research report is one of a series of new reports from The Business Research Company that provides large and small-scale bioprocessing market statistics, including large and small-scale bioprocessing industry global market size, regional shares, competitors with a large and small-scale bioprocessing market share, detailed large and small-scale bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the large and small-scale bioprocessing industry. This large and small-scale bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large and small-scale bioprocessing market size has grown rapidly in recent years. It will grow from $59.63 billion in 2024 to $67.66 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to medical industry growth, regulatory standards, technological advancements, pharmaceutical and biotechnology growth, and food safety concerns.

The large and small-scale bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $108.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, the expansion of pharmaceutical and biotechnology sectors, technological innovations, regulatory pressures, rising awareness of food safety, and the aftermath of the COVID-19 pandemic. Major trends in the forecast period include the adoption of advanced technologies, geographical expansion, outsourcing of sterilization services, sustainable practices, hybrid sterilization techniques, and customized sterilization solutions.

The forecast of 12.6% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biopharmaceutical manufacturers by driving up the cost of single-use bioreactors and filtration systems imported from Sweden and Singapore, exacerbating drug production delays and increasing biologics development expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for biologics is poised to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics encompass medicinal products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The escalating demand for biologics is attributed to advancements in biotechnology, enhanced understanding of disease mechanisms, and the desire for targeted and personalized therapies. Both large-scale and small-scale bioprocessing play vital roles in the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for early-stage development, optimization, and feasibility studies, whereas large-scale bioprocessing ensures efficient, consistent, and regulatory-compliant production of biologics for commercial distribution. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Hence, the growing demand for biologics is a driving force behind the growth of the large and small-scale bioprocessing market.

Key players in the large and small-scale bioprocessing market are innovating their product offerings, such as introducing single-use centrifuge systems, to provide customers with enhanced features. Single-use centrifuge systems are disposable and pre-sterilized devices designed for the separation of biological materials in bioprocessing. For instance, in September 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the DynaSpin Single-Use Centrifuge system. This system aims to enhance large-scale cell culture harvesting by simplifying the separation process, reducing the need for depth filtration cartridges, and delivering advantages such as improved product yield, operational efficiency, cost savings, and sustainable practices in biologics production. The DynaSpin system contributes to cost reduction in production and supports sustainability objectives by significantly reducing material usage and waste compared to traditional harvest systems.

In December 2022, Merck KGaA, a German science and technology company, purchased Erbi Biosystems for an undisclosed sum. This acquisition bolsters Merck's portfolio in upstream therapeutic proteins, facilitating scalable cell-based perfusion bioreactor processes spanning from 2 milliliters (mL) to 2000 liters (L). Erbi Biosystems, based in the US, offers a range of bioprocessing solutions catering to both large and small-scale applications.

Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd

North America was the largest region in the large and small-scale bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the large and small-scale bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The large and small-scale bioprocessing market consists of revenues earned by entities by providing plant cell bioprocessing, microbial bioprocessing, animal cell bioprocessing, and algal bioprocessing. The market value includes the value of related goods sold by the service provider or included within the service offering. The large and small-scale bioprocessing market also includes sales of shakers, incubators, and cell culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large And Small-Scale Bioprocessing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large and small-scale bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for large and small-scale bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The large and small-scale bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Large And Small-Scale Bioprocessing Market Characteristics

3. Large And Small-Scale Bioprocessing Market Trends And Strategies

4. Large And Small-Scale Bioprocessing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Large And Small-Scale Bioprocessing Growth Analysis And Strategic Analysis Framework

6. Large And Small-Scale Bioprocessing Market Segmentation

7. Large And Small-Scale Bioprocessing Market Regional And Country Analysis

8. Asia-Pacific Large And Small-Scale Bioprocessing Market

9. China Large And Small-Scale Bioprocessing Market

10. India Large And Small-Scale Bioprocessing Market

11. Japan Large And Small-Scale Bioprocessing Market

12. Australia Large And Small-Scale Bioprocessing Market

13. Indonesia Large And Small-Scale Bioprocessing Market

14. South Korea Large And Small-Scale Bioprocessing Market

15. Western Europe Large And Small-Scale Bioprocessing Market

16. UK Large And Small-Scale Bioprocessing Market

17. Germany Large And Small-Scale Bioprocessing Market

18. France Large And Small-Scale Bioprocessing Market

19. Italy Large And Small-Scale Bioprocessing Market

20. Spain Large And Small-Scale Bioprocessing Market

21. Eastern Europe Large And Small-Scale Bioprocessing Market

22. Russia Large And Small-Scale Bioprocessing Market

23. North America Large And Small-Scale Bioprocessing Market

24. USA Large And Small-Scale Bioprocessing Market

25. Canada Large And Small-Scale Bioprocessing Market

26. South America Large And Small-Scale Bioprocessing Market

27. Brazil Large And Small-Scale Bioprocessing Market

28. Middle East Large And Small-Scale Bioprocessing Market

29. Africa Large And Small-Scale Bioprocessing Market

30. Large And Small-Scale Bioprocessing Market Competitive Landscape And Company Profiles

31. Large And Small-Scale Bioprocessing Market Other Major And Innovative Companies

32. Global Large And Small-Scale Bioprocessing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Large And Small-Scale Bioprocessing Market

34. Recent Developments In The Large And Small-Scale Bioprocessing Market

35. Large And Small-Scale Bioprocessing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기